JNJ Johnson & Johnson
$268.73
Johnson & Johnson (JNJ) Earnings News
Earnings press releases, previews and reviews for Johnson & Johnson (JNJ), newest first. Our most recent is review: J&J Tops Consensus but Misses the Whisper as Deal Costs Swamp a Pharma-Led Sales Acceleration.
Tuesday
October 13, 2026
11:36 AM ET
J&J Tops Consensus but Misses the Whisper as Deal Costs Swamp a Pharma-Led Sales Acceleration
Earnings Whispers · Review
Tuesday
October 13, 2026
6:20 AM ET
Johnson & Johnson reports Q3 2026 results, raises 2026 guidance
Monday
October 5, 2026
9:27 AM ET
J&J's Drug Launches Must Keep Outrunning a Stalled Cardiovascular Device Business
Earnings Whispers · Preview
Monday
August 31, 2026
5:08 PM ET
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
Wednesday
July 29, 2026
5:42 PM ET
Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation
Wednesday
July 29, 2026
5:28 PM ET
Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset
Wednesday
July 15, 2026
6:20 AM ET
Johnson & Johnson reports Q2 2026 results, raises 2026 outlook
Wednesday
May 27, 2026
4:22 PM ET
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results